Author:
Grossman Tim,Morton Kathryn A.
Reference2 articles.
1. Imaging of prostate-specific membrane antigen using [18F]DCFPyL;Rowe;Pet Clin,2017
2. Lantheus press release: lantheus receives U.S. Approval of PYLARIFY (piflufolastat F 18) injection, the first and only commercially available PSMA PET imaging agent for prostate cancer,2021